A Case of an Unusually Aggressive Cutaneous Anaplastic Large T-Cell Lymphoma in a Young Patient
Journal Title: International Journal of Cancer Studies & Research (IJCR) - Year 2016, Vol 5, Issue 4
Abstract
Primary Cutaneous Anaplastic Large‑cell Lymphoma (PC‑ALCL) is the second most common cutaneous T‑cell Lym‑ phoma. PCALCL is composed of large cells with an anaplastic, pleomorphic, or immunoblastic cytomorphology, and expression of the CD30 antigen by the majority (>75%) of tumor cells .Wehere by report a case of unusually aggressive PC‑ALCL in a young adult.
Authors and Affiliations
S Elloudi
Keywords
Related Articles
- EP ID EP198263
- DOI 10.19070/2167-9118-1600021
- Views 95
- Downloads 0
Mixed Adenosquamous Histology is Associated with Poorer Survival of Cervical Cancer Stage 1b
Background: Evaluation of histopathological factors for women with radical hysterectomy a.m. Okabayashi for cervical cancer in stage 1bwith similar pre- and postoperative treatment Methods: Data on 141 women with cervic...
Patient-Centered Outcomes Research In Advanced Stage Lung Cancer: Study Design and Population
Background: In 2013, researchers at the University of Nebraska Medical Center (UNMC) received funding from the Patient-Centered Outcomes Research Institute to establish a study that outlines treatment options for patient...
Store-Operated Calcium Channel and Cancer
The increase of intracellular Ca2+ concentration is an important mechanism that regulates a variety of physiological processes ranging from exocytosis to gene regulation and cell proliferation [1]. Calcium release from...
A Case of an Unusually Aggressive Cutaneous Anaplastic Large T-Cell Lymphoma in a Young Patient
Primary Cutaneous Anaplastic Large‑cell Lymphoma (PC‑ALCL) is the second most common cutaneous T‑cell Lym‑ phoma. PCALCL is composed of large cells with an anaplastic, pleomorphic, or immunoblastic cytomorphology, and ex...
Validation Trial of a Novel Marker of Delayed Chemotherapy-induced Emesis
Post hoc analyses of study data suggested that the ratio of substance P to 5-HIAA/creatinine was a novel marker associated with risk of developing delayed chemotherapy-induced emesis. In order to verify this finding, a n...